
Global Public Health and Epidemiology Congress | G-PHEC 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Global Public Health and Epidemiology Congress | G-PHEC 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Global Public Health and Epidemiology Congress (G-PHEC) 2026
The Global Public Health and Epidemiology Congress (G-PHEC 2026) is a hybrid international congress taking place September 21–23, 2026 in London, United Kingdom and also online. Positioned around the theme Innovation and Equity in Public Health, G-PHEC 2026 is designed to strengthen global knowledge-sharing, research collaboration, and practical solutions for healthier communities.
G-PHEC 2026 brings together public health experts, epidemiologists, researchers, policymakers, healthcare professionals, academicians, and industry leaders from across the world. Through its hybrid format, the congress supports both in-person participation in London and virtual engagement, helping increase accessibility and inclusivity for a truly global audience.
The congress features a comprehensive scientific program that includes keynote lectures, oral and poster presentations, expert panels, workshops, and roundtable discussions. Attendees can expect opportunities to engage with current evidence, policy perspectives, and emerging innovations that are shaping the public health and epidemiology landscape.
Scientific and discussion topics cover a broad spectrum of public health and epidemiology priorities, including:
- Infectious disease surveillance
- Non-communicable disease (NCD) trends
- Environmental health
- Biostatistics
- Health policy and health equity
- Global health strategies
- Digital health
- Outbreak preparedness and pandemic response
In addition, G-PHEC 2026 supports early-career researchers and students by providing avenues to present work and engage with global mentors. Institutional and industry partners are also positioned to showcase new technologies, public health interventions, and collaboration opportunities aligned with modern public health needs.
The event is promoted as a CPD accredited conference, offering 15+ CPD credits, and includes group registration savings where registering 3+ colleagues unlocks 20% team discount. The congress also highlights journal collaborations with potential up to FREE publication-related benefits, depending on the participation pathway and program terms.
For participation planning, G-PHEC 2026 notes that Early Registration closes on July 15, 2026, while the Second Phase of Abstract Submission closes on July 14, 2026. The congress brochure and detailed program information are available through the official event pages.
Data sheet
| Event Name | Global Public Health and Epidemiology Congress | G-PHEC 2026 |
| Event Date | September 21–23, 2026 |
| Event Status | Upcoming |
| Venue | London, United Kingdom and Online (official website listing) |
| City | London |
| State / Region | England |
| Country | United Kingdom |
| Organizer | Organizer details are listed on the official website; specific organizing entity not fully confirmed in the provided text |
| Official Event Website | globalpublichealthcongress.com |
| Event Type | Hybrid conference / congress |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Education & Training; Wellness, Health & Fitness |
| Audience Reach | Global, with strong UK and Europe participation potential |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to Medium; public registration content confirms event format, dates, and theme, but not a verified headcount |
| Main Purpose of Event | To share public health and epidemiology research, innovations, policy approaches, and collaboration opportunities in a hybrid international forum |
G-PHEC 2026 is a hybrid public health and epidemiology congress focused on innovation, equity, research exchange, and cross-border collaboration. The official agenda emphasizes keynote lectures, scientific sessions, oral and poster presentations, expert panels, workshops, and roundtables covering infectious disease surveillance, non-communicable disease epidemiology, environmental health, biostatistics, digital health, outbreak preparedness, and pandemic response.
The event is relevant for institutions and organizations seeking evidence-based public health solutions, research partnerships, policy insight, and academic visibility. It is especially useful for universities, healthcare institutions, public-sector health bodies, researchers, NGOs, and industry partners supporting public health technologies, analytics, intervention programs, and health system improvement initiatives.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Public health leadership | National health agencies, public health institutes, ministries of health | Strategy, program adoption, policy direction | High relevance for health analytics, surveillance, training, and population-health solutions |
| Procurement and sourcing teams | Hospitals, universities, research institutes, government bodies, NGOs | Vendor selection, contracting, renewals | Important for software, lab services, training, and consulting suppliers |
| Researchers and academics | Universities, medical schools, schools of public health | Research influence, method selection, grant collaboration | Strong fit for data platforms, publication support, and research tools |
| Healthcare operations leaders | Hospitals, clinics, integrated health systems | Service delivery, operational improvement | Relevant for workflow, monitoring, and patient-impact solutions |
| Epidemiologists and biostatisticians | Public agencies, universities, pharma, CROs, research centers | Methodology, evidence generation, study design | High fit for analytics, dashboards, data management, and research services |
| NGO and humanitarian program teams | Global health NGOs, aid organizations, foundations | Program buying, partnerships, implementation | Relevant for health program tools, training, monitoring, and field services |
| Digital health and informatics leaders | Healthtech firms, hospitals, public health bodies | Platform evaluation, tech adoption | Strong fit for software, interoperability, AI, and data infrastructure vendors |
| Pharma and life sciences stakeholders | Pharmaceutical companies, CROs, medtech firms | Research collaboration, evidence generation, public health engagement | Relevant for studies, real-world evidence, and population-health partnerships |
| Students and early-career professionals | Universities, training programs, fellowships | Learning, networking, career development | Lower direct buying power, but useful for awareness and academic pipeline |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: London | High likelihood of UK-based institutions and professionals | High | London is a major global health, university, and life sciences hub |
| Host region: England | UK public health bodies, NHS organizations, universities, research networks | High | Strong domestic relevance for public-sector and academic procurement |
| Nearby business hubs | Oxford, Cambridge, Reading, Slough, Birmingham, Manchester | Medium to High | Supports attendance from healthtech, research, and hospital ecosystems |
| National reach | UK-wide public health, healthcare, and academic stakeholders | High | Hybrid format increases the likelihood of broader UK participation |
| International reach | Global researchers, clinicians, NGOs, and health policy professionals | Medium to High | The official description explicitly positions the congress as international |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The congress is explicitly described as international and hybrid, with participation positioned for global public health and epidemiology audiences. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| University of Arizona School of Medicine | Academic / research | Named on official organizer committee/speakers list; relevant to public health research and collaboration | arizona.edu | Dean, Professor, Research Director, Epidemiology Lead | Confirmed Speaker Organization |
| Walden University | Academic / education | Named on official organizer committee/speakers list; strong alignment with public health education | waldenu.edu | Program Director, Faculty Lead, Research Chair, Department Head | Confirmed Speaker Organization |
| World Lifestyle Medicine | Health / association | Named on official committee/speakers list; relevant to population health and prevention | worldlifestylemedicine.com | Executive Director, Partnerships Director, Program Lead | Confirmed Speaker Organization |
| UK Health Security Agency | Government / public health | High-fit public health buyer for surveillance, outbreak response, and analytics | gov.uk/government/organisations/uk-health-security-agency | Director, Head of Surveillance, Procurement Lead, Program Manager | Strong Market Fit, Attendance Not Confirmed |
| NHS England | Government / healthcare | Potential buyer for health data, prevention, training, and population health services | england.nhs.uk | Director of Public Health, Procurement Manager, Analytics Lead | Strong Market Fit, Attendance Not Confirmed |
| Department of Health and Social Care | Government administration | Policy and funding influence for public health programs and partnerships | gov.uk/government/organisations/department-of-health-and-social-care | Policy Director, Commercial Manager, Program Lead | Strong Market Fit, Attendance Not Confirmed |
| London School of Hygiene & Tropical Medicine | Academic / research | Premier public health and epidemiology institution; ideal research and conference buyer | lshtm.ac.uk | Professor, Institute Director, Research Manager | Strong Market Fit, Attendance Not Confirmed |
| University College London | Academic / research | Large research university with public health, medicine, and data science stakeholders | ucl.ac.uk | Head of Department, Professor, Research Director, Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Imperial College London | Academic / research | Relevant for epidemiology, biosciences, and health systems research | imperial.ac.uk | Research Lead, Faculty Head, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| King’s College London | Academic / research | Healthcare and public policy research buyer with strong London relevance | kcl.ac.uk | Dean, Research Manager, Public Health Lead | Strong Market Fit, Attendance Not Confirmed |
| Wellcome Trust | Foundation / research funding | Major funder of health research and innovation, highly relevant to congress themes | wellcome.org | Program Director, Grants Manager, Science Lead | Strong Market Fit, Attendance Not Confirmed |
| World Health Organization | International public health | Global policy, epidemiology, and outbreak preparedness stakeholder | who.int | Technical Officer, Program Manager, Epidemiologist | Strong Market Fit, Attendance Not Confirmed |
| UNICEF | International NGO | Public health, child health, immunization, and data programs align strongly | unicef.org | Health Specialist, Program Officer, Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Médecins Sans Frontières | NGO / humanitarian health | Relevant for outbreak response, field epidemiology, and healthcare delivery | msf.org | Medical Coordinator, Program Manager, Logistics Lead | Strong Market Fit, Attendance Not Confirmed |
| FHI 360 | Global health NGO | Programs in health, research, and capacity building align closely | fhi360.org | Director, Technical Advisor, Business Development | Strong Market Fit, Attendance Not Confirmed |
| GSK | Pharma / life sciences | Public health research, vaccine, and epidemiology collaboration potential | gsk.com | Medical Affairs Director, Epidemiology Lead, Partnerships Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Public Health | Public health / healthcare | Director / VP | Owns program strategy, partnerships, and solution adoption |
| 2 | Epidemiologist | Research / analytics | Mid to senior | Technical influencer for data, surveillance, and study design |
| 3 | Biostatistician | Research / statistics | Mid to senior | Influences analytic tools, datasets, and evidence generation |
| 4 | Public Health Program Manager | Programs / operations | Manager / senior manager | Implements funded initiatives and evaluates vendors |
| 5 | Procurement Manager | Procurement / commercial | Manager | Purchasing and contracting authority for services and technology |
| 6 | Research Director | Research / academic leadership | Director | Sponsors studies, grants, and partnerships |
| 7 | Head of Surveillance | Public health intelligence | Director / head | Key stakeholder for surveillance systems and outbreak tools |
| 8 | Health Informatics Lead | Digital health / IT | Manager to director | Decision-maker for data platforms, integration, and reporting |
| 9 | Dean / Faculty Head | Higher education | Senior leadership | Influences academic partnerships, sponsorship, and conference participation |
| 10 | Business Development Director | Partnerships / commercial | Director | Drives collaborations, sponsorships, and market expansion |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Primary end-user base for population health and epidemiology programs | Clinical research, surveillance, analytics, and workflow solutions |
| 2 | Government Administration | Public-sector health agencies and policy organizations | Health programs, procurement, policy, and oversight |
| 3 | Higher Education | Strong concentration of researchers, faculty, and academic buyers | Research tools, publications, training, and partnerships |
| 4 | Research | Methodology, evidence generation, and study design are central themes | Analytics, data collection, and research support services |
| 5 | Pharmaceuticals | Public health, epidemiology, and real-world evidence relevance | Medical affairs, epidemiology, and evidence generation |
| 6 | Biotechnology | Innovation and research-focused buying base | Research collaboration, public health tools, diagnostics |
| 7 | Information Technology & Services | Digital health, data integration, and analytics solutions are highly relevant | EHR integration, dashboards, analytics, workflow automation |
| 8 | Information Services | Knowledge management and public health intelligence use cases | Data enrichment, reporting, evidence platforms |
| 9 | Nonprofit Organization Management | NGOs and global health charities are likely attendees | Program management, grants, monitoring & evaluation |
| 10 | International Trade & Development | Global health partnerships and development programs | Cross-border health initiatives, technical assistance |
| 11 | Health, Wellness & Fitness | Prevention, population health, and lifestyle medicine themes are present | Wellness programs, prevention, health promotion |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Organizer site does not publish a verified attendance count in the provided text | Use caution in outreach forecasting |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified exhibitor directory in provided content | Hybrid congress appears science-led rather than expo-heavy |
| Buyer count | Not publicly confirmed | Unconfirmed | No verified buyer list published in the provided text | Likely composed of academic, public-sector, and health innovation stakeholders |
| Speaker count | Not publicly confirmed | Unconfirmed | Partial organizing committee names shown on official site | Speaker page exists; count not visible in provided text |
| Historical attendance | No verified figure available | Not confirmed | No reliable prior-year attendance evidence included in provided source text | Attendance figure not publicly confirmed by the organizer. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Public health surveillance | Faster outbreak detection and monitoring | Demonstrate dashboards, alerts, and reporting workflows | Analytics software, data platforms, alerts |
| Epidemiology research | Study design, data integrity, evidence generation | Position solutions for research productivity and data quality | CRO support, data management, biostatistics |
| Digital health | Integrated data, telehealth, and interoperability | Show technical fit with health systems and public health agencies | Software, APIs, integration, cloud hosting |
| Health equity | Population-specific interventions and inclusive access | Align on outcomes, access, and community impact | Program design, community engagement, reporting |
| Outbreak preparedness | Readiness planning and response protocols | Frame as risk reduction and resilience | Emergency response tools, training, logistics |
| Training and workforce development | Upskilling staff and early-career professionals | Offer certified courses and education programs | E-learning, workshops, CPD content |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The congress attracts public health, epidemiology, research, and healthcare stakeholders with direct buying influence. |
| Decision-maker availability | High | Likely senior academic, government, and program leadership attendance, though not fully published. |
| Data collection potential | Medium | The official site shows agenda and committee information, but no verified current-year attendee directory. |
| Apollo targeting potential | Very High | Clear targeting paths exist across academia, government health, pharma, and NGOs. |
| Geographic targeting potential | High | Strong UK concentration with international hybrid reach. |
| Best outreach approach | Educational + research-led | Lead with public health outcomes, evidence, collaboration, and compliance rather than pure sales messaging. |
| Overall lead quality | High | Strong fit for lead generation in health research, analytics, training, and public-sector engagement. |
| Best use case | B2B attendee list building | Best for building targeted outreach lists across public health, academia, and healthcare innovation segments. |
| Limitations / risks | Limited public attendee data | No verified current-year attendee list or headcount was available in the official text provided. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Government Administration; Higher Education; Research; Pharmaceuticals; Biotechnology; Information Technology & Services; Nonprofit Organization Management; Health, Wellness & Fitness; International Trade & Development | Capture the most relevant buying organizations |
| Departments | Public Health; Research; Operations; Procurement; Healthcare Administration; IT; Partnerships; Programs | Reach functional owners and influencers |
| Seniority | Manager; Director; VP; CXO; Head; Professor; Principal Investigator | Prioritize decision-makers and technical approvers |
| Job titles | Director of Public Health; Epidemiologist; Biostatistician; Research Director; Procurement Manager; Program Manager; Health Informatics Lead; Medical Affairs Director; Head of Surveillance; Dean | Target roles most likely to engage with the congress themes |
| Geography | United Kingdom; Ireland; Western Europe; North America; global public health hubs | Align with hybrid event participation and international relevance |
| Employee size | 51–200; 201–500; 501–1000; 1000+ | Prioritize institutions and organizations with budget and buying power |
| Keywords | public health, epidemiology, surveillance, outbreak, biostatistics, global health, health equity, digital health, population health, research | Refine search to event-relevant stakeholders |
| Company type | Private; Public; Nonprofit; Government | Broaden coverage across the public health ecosystem |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Global Public Health and Epidemiology Congress official website | Official organizer/event source | Event title, dates, hybrid format, theme, agenda topics, committee names, CPD notes | High |
| Official conference page content provided by user | Primary source text excerpt | Confirmed September 21–23, 2026 schedule, London/online format, scientific focus, speaker/committee references | High |
| Organizer and speakers sections on official site | Official organizer/speaker listing | Named speaker/committee organizations including University of Arizona School of Medicine, Walden University, and World Lifestyle Medicine | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Global Public Health and Epidemiology Congress | G-PHEC 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.